Locations
Bayer Canada
Latest News
Health Canada approves additional indication for NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel
Our Businesses
We research, develop and market innovative products that improve the health of people and plants. Our business comprises three core divisions and one business unit. Learn more about it here.